Immuneering Corp Class A (IMRX)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | GENGOS, ANDREW | Chief Financial Officer | Stock Option | Acquisition | 650,000 | 0 |
| Jun 23, 2026 | ZESKIND, BENJAMIN J. | Director, PRESIDENT AND CEO | Class A Common Stock | Acquisition | 2,400 | 4.562 |
| Jun 15, 2026 | HALL, BRETT MATTHEW | CHIEF SCIENTIFIC OFFICER | Class A Common Stock | Acquisition | 6,035 | 4.15 |
| Jun 11, 2026 | KEATING, LAURIE | Director | Stock Option | Acquisition | 33,350 | 0 |
| Jun 11, 2026 | HAUSMAN, DIANA | Director | Stock Option | Acquisition | 33,350 | 0 |
| Jun 11, 2026 | CARPENTER, ROBERT J | Director | Stock Option | Acquisition | 33,350 | 0 |
| Jun 11, 2026 | FEINBERG, PETER | Director | Stock Option | Acquisition | 33,350 | 0 |
| Jun 11, 2026 | SCHALL, THOMAS J. | Director | Stock Option | Acquisition | 33,350 | 0 |
| Mar 13, 2026 | NEUFELD, LEAH R | CHIEF PEOPLE OFFICER | Class A Common Stock | Acquisition | 3,628 | 4.293 |
| Feb 3, 2026 | HALL, BRETT MATTHEW | CHIEF SCIENTIFIC OFFICER | Stock Option | Acquisition | 344,000 | 0 |
| Feb 3, 2026 | BRAKEWOOD, HAROLD EUGENE | Chief Business Officer | Stock Option | Acquisition | 140,000 | 0 |
| Feb 3, 2026 | NEUFELD, LEAH R | CHIEF PEOPLE OFFICER | Stock Option | Acquisition | 140,000 | 0 |
| Feb 3, 2026 | MATUSHANSKY, IGOR | Chief Medical Officer | Stock Option | Acquisition | 140,000 | 0 |
| Feb 3, 2026 | MORALES, MALLORY | SVP Finance, CAO | Stock Option | Acquisition | 140,000 | 0 |
| Feb 3, 2026 | BOOKMAN, MICHAEL | CHIEF LEGAL OFFICER, SECRETARY | Stock Option | Acquisition | 176,000 | 0 |
| Feb 3, 2026 | ZESKIND, BENJAMIN J. | Director, PRESIDENT AND CEO | Stock Option | Acquisition | 688,000 | 0 |
| Jan 16, 2026 | BRAKEWOOD, HAROLD EUGENE | Chief Business Officer | Class A Common Stock | Acquisition | 5,250 | 4.76 |
| Jan 15, 2026 | HALL, BRETT MATTHEW | CHIEF SCIENTIFIC OFFICER | Class A Common Stock | Acquisition | 2,298 | 4.57 |
| Jan 15, 2026 | SCHALL, THOMAS J. | Director | Class A Common Stock | Acquisition | 21,645 | 4.668 |
| Jan 13, 2026 | NEUFELD, LEAH R | CHIEF PEOPLE OFFICER | Class A Common Stock | Acquisition | 2,626 | 4.153 |
| Jan 12, 2026 | FEINBERG, PETER | Director | Class A Common Stock | Acquisition | 20,000 | 4.345 |
| Jan 1, 2026 | FEINBERG, PETER | Director | Stock Option | Acquisition | 7,888 | 0 |
| Jan 1, 2026 | KEATING, LAURIE | Director | Stock Option | Acquisition | 7,888 | 0 |
| Oct 3, 2025 | FEINBERG, PETER | Director | Class A Common Stock | Acquisition | 7,500 | 6.67 |
| Oct 1, 2025 | NEUFELD, LEAH R | CHIEF PEOPLE OFFICER | Class A Common Stock | Acquisition | 800 | 6.379 |
| Oct 1, 2025 | BOOKMAN, MICHAEL | CHIEF LEGAL OFFICER, SECRETARY | Class A Common Stock | Acquisition | 1,020 | 6.83 |
| Oct 1, 2025 | MORALES, MALLORY | Chief Accounting Officer | Class A Common Stock | Acquisition | 300 | 6.39 |
| Sep 30, 2025 | FEINBERG, PETER | Director | Class A Common Stock | Acquisition | 7,500 | 7.031 |
| Sep 29, 2025 | FEINBERG, PETER | Director | Class A Common Stock | Acquisition | 5,000 | 7.18 |